Fluidigm Corp. is buying DVS Sciences Inc. for $208 million.

CVS develops single-cell protein analysis systems, which are used in biological research.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.